30-Day morbidity and mortality of bariatric metabolic surgery in adolescence during the COVID-19 pandemic - The GENEVA study.
Rishi SinghalTom WigginsJonathan SuperAayed AlqahtaniEvan P NadlerChristian LudwigAbd TahraniKamal Mahawarnull nullPublished in: Pediatric obesity (2021)
MBS in adolescents with obesity is safe during the COVID-19 pandemic when performed within the context of local precautionary procedures (such as pre-operative testing). The 30-day morbidity rates were similar to those reported pre-pandemic. These data will help facilitate the safe re-introduction of MBS services for this group of patients.
Keyphrases
- weight loss
- end stage renal disease
- ejection fraction
- sars cov
- newly diagnosed
- healthcare
- young adults
- metabolic syndrome
- chronic kidney disease
- primary care
- type diabetes
- coronavirus disease
- physical activity
- insulin resistance
- depressive symptoms
- mental health
- prognostic factors
- roux en y gastric bypass
- bariatric surgery
- acute coronary syndrome
- body mass index
- atrial fibrillation
- data analysis
- artificial intelligence